Bank of Montreal’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Bank of Montreal’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-620	Closed	-$14.1K	–	4354
2023 Q1	$14.1K	Hold	620	–	–	﹤0.01%	3576
2022 Q4	$13K	Buy	+620	New	+$11.7K	﹤0.01%	3751
2022 Q2	–	Sell	-4,207	Closed	-$332K	–	4523
2022 Q1	$332K	Buy	+4,207	New	+$520K	﹤0.01%	3131
2021 Q3	–	Sell	-12,645	Closed	-$3.18M	–	3975
2021 Q2	$3.18M	Buy	+12,645	New	+$3.85M	﹤0.01%	1818

Other funds holding VINC

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SRC

Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Bank of Montreal's VINC Position: Q2 2023 in Review

Bank of Montreal sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q2 2023, closing a stake of 620 shares — an estimated $14.1K sold.

Bank of Montreal first reported a position in VINC in Q2 2021 and held it in 4 quarters. The position peaked at $3.18M in Q2 2021. 35 funds tracked by Wall St. Rank hold VINC as of Q2 2023.

Bank of Montreal reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Bank of Montreal sold 620 Vincerx Pharma, Inc. Common Stock shares in Q2 2023, an estimated $14.1K.
Bank of Montreal first reported a position in Vincerx Pharma, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Bank of Montreal's Vincerx Pharma, Inc. Common Stock position peaked at $3.18M in Q2 2021.
35 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q2 2023.

Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.